In this investigation, the genotoxic properties of mestranol were examined in vitro. Human lymphocyte cultures were exposed for 72 h to mestranol at concentrations of 7.5, 15 and 30 µg/g. The genotoxic effects of the chemosterilant were assessed by numerical and structural chromosome aberrations.
INTRODUCTION
The number of mouse-like rodent populations has been growing continuously during evolution and accordingly and caused damages infl icted to humans directly or indirectly. Owing to the obvious economic and epidemiological/epizootiological importance of rodents, it is necessary to carry out a systematic rodent control, which means to reduce the populations of harmful rodents to tolerable levels, all of which is aimed at preserving the health of people, domestic animals and game, as well as tangible assets. The use of mechanical, physical, biological and chemical means of combat against mouse-like rodents has not lead to satisfactory results, that is, satisfactory results can be achieved in small buildings or in larger on condition they are not heavily invaded.
Given the growing emergence of resistance of rodents to rodenticides, [1] there is a necessity to produce novel methods, or novel chemical compounds in order to fi ght and regulate the populations of mouse-like rodents. One of the products, available on the market, are ready-to-use baits based on chemosterilants (mestranol). The mode of action of chemosterilants is based on their ability to lead to temporary or permanent sterility of males or females only, or both genders of harmful rodents. They may directly or indirectly impair the development or maturation of gametes prior to or after copulation, prevent the fusion of the egg cell and the sperm cell and, fi nally, the implantation of the fertilized ovum in the uterus [2] . Further, they can suppress the sexual development of the offspring and cause irreversible infertility, cause death in the offspring due to the decrease in maternal lactation [3] .
Given that it has been confi rmed that some pesticides [4, 5] especially rodenticides, mainly based on coumarin and indandione, [6] [7] [8] [9] [10] [11] may cause cytological and mitotic changes, and chromosomal aberrations, and that there are scarce data on the genotoxic effects of chemosterilants, it has been decided that in this work we focus on the possible genotoxic effects of mestranol on human lymphocytes in vitro.
MATERIAL AND METHODS
The genotoxic effects of mestranol (17-α-ethynylestradiole-3-methyl ether), a powerful chemosterilant, were assessed in vitro.
Mestranol is a steroid chaemosterilant. Its effects include the inhibition of ovulation, prevention and disruption of implantation, the absorption of the embryo, miscarriage and disrupted sexual development of the offspring. It leads to temporary sterility in mouse-like rodents when used in the dose of (30-50 µg/g) when ingested at the age of 28-days.
Human lymphocyte culture
Human lymphocyte cells were cultured according to Evans and O'Riordan [13] . Blood samples (5-10 ml) are normally taken from a female donor, 20-25 years old, by venipuncture using a 10-20 ml sterile syringe. The blood is then immediately transferred to a suitable sized sterile tube containing lithium heparin at concentrations of 100 IU/ml of blood. The cultures were seeded immediately after the blood was taken in sterile 20 ml vials.
Cells were cultured in Parker 199 medium supplemented with fetal calf serum. In 30ml sterile vials 0.8 ml of whole blood is added to 10 ml of culture medium.
The pH of the nutrient medium was maintained at 6.8-7.2 by addition of bicarbonate buffer. To minimize the risk of culture contamination, 100 IU / ml Penicillin and Streptomycin were added to the medium.
Phytohemagglutinin-PHA was used to initiate lymphocytes mitotic divisions, otherwise stopped in the Go phase. Immediately after the addition of PHA, 7.5 µg/g, 15 µg/g and 30 µg/g of mestranol were added to the cultures.
The culture vials were placed in the incubator at 37 °C for 72 h. During the last 3 h prior to harvesting the cells, a spindle inhibitor colchicine (Merck) was added to the culture at a volume that provided a fi nal concentration of 0.5 mg / ml to block the spindle, providing suffi cient metaphase cells for chromosomal analysis.
Chromosome analyses were performed in cells marked in Carman solution and diluted in 0.56% KCl. [12] .
To study the genotoxicity of mestranol, human lymphocytes were exposed to 7.5, 15 and 30 µg/g of mestranol in the cell culture for three days. The mitotic activity of the lymphocytes and the occurrence of numerical and structural aberrations were assessed.
Statistical analysis
The results obtained were analyzed with Student's t-test (Statgraphics 5.0-Statistical Graphics Corporation, USA Programme).
RESULTS
The results obtained in the research into the infl uence of mestranol in concentrations of 7.5, 15 and 30 µg/g of culture on the occurrence of numerical chromosome aberrations in human lymphocytes in vitro Table 1 . In a three-day treatment three experimental and a control group of cells were examined. In each experimental group 96-100 metaphase fi gures were analysed, and 62 were selected from the control. In the solvent control, a diploid number of chromosomes was detected in 98.38% of the cells analyzed and aneuploidy was found in 1.61%, polyploidy did not occur. In mestranol-treated cultures the percentage of lymphocytes with aneuploidy was dosedependent: in lymphocytes treated with the maximum dose it reached 11.68%, out of which the majority -9.09% of the total number of examined -were with haploid metaphases. Along with the increase in the mestranol dose -in 15 and 30 µg/gthere was an increase in the number of polyploid cells from 0.0% to 1.29%. This increase in the effect of mestranol was statistically signifi cant (p<0.01). The frequency of numerical aberrations in all of the three mestranol doses was signifi cantly higher in comparison to the control (p<0.01), with the exception of polyploidy, which did not increase signifi cantly (p>0.05).
The second part of the research consisted of the assessment of structural chromosome aberrations in human lymphocyte cultures exposed to various doses (7.5, 15 and 30 µg/g culture medium) of mestranol for 72 h. The average values of chromosomal damages are shown in Table 2 . Table 3 . shows the results of chromosome aberrations produced by mestranol in human lymphocyte cultures. The study was performed on a control and three experimental groups of human lymphocytes who were exposed to 7.5, 15 and 30 µg/g of mestranol for three days. In each group 700-800 cell cultures were analyzed. The control experimental group showed an average mitotic activity of 5.71 with more distinct individual variability, ranging from 4-7. During the treatment of human lymphocytes, the mitotic activity decreased depending on the dose. The lowest mitotic activity of 2.57 was registered in the group which was exposed to 30 µg/g of mestranol.
A low individual variability was present in all experimental groups.
DISCUSSION
The research was done on three experimental groups and one control group of cultures. In all the groups on average 100 metaphase fi gures have been analysed.
In the control group chromosomal gaps and fragments occurred sporadically (1%). Robertsonian translocations have not been noticed. With the increase in the dose, at the same length of exposition, the frequency of structural aberrations increased and reached its maximum at the highest dose of mestranol (30 µg/g of culture medium).
The increase was dose-dependent and signifi cant (p<0.01), with the exception of Robertsonian translocations, which were increased signifi cantly only in cultures treated with the highest dose of mestranol (30 µg/g culture medium). Statistically signifi cant (p<0.01) differences were noticed between doses 30 µg/g and 7.5 µg/g. Also, statistically signifi cant differences between the levels of gaps and fragments, in comparison to Robertsonian translocations (p<0.01) were recorded, while the numbers of gaps and fragments were not signifi cantly different.
In addition to this, the statistically signifi cant differences in the levels of gaps and fragments are comparable to Robertsonian translocations (p<0.01), whilst the number of chromosome breaks did not change signifi cantly.
Based on the results of this research it is obvious that mestranol in the doses administered may do damage to the genetic material in human lymphocyte cultures exposed for 72 h. Cytogenetic changes were recorded also due to some other rodenticides, [14] [15] [16] as well as in a number of other substances in use in veterinary medicine [17] [18] [19] [20] . The majority of those researches were performed in vitro, in human lymphocyte cultures, [21, 22] similarly to our study. Besides genotoxic effects, as a fi nal consequence to the genetic material, which have been detected in our research on mestranol, [23] [24] [25] this substance leads to infertility predominantly in male rodents, to temporary infertility in monkeys, but does not affect fertility in mice and hares.
CONCLUSIONS
In human peripheral blood lymphocyte cultures exposed for 72 h to various doses of mestranol -7.5, 15 and 30 µg/g medium, a mitotic suppression activity was noticed when compared to the negative control.
Mestranol in various doses -7.5, 15 and 30 µg/g, in a three-day treatment expressed a mitotic suppression activity in lymphocyte cells of peripheral blood in vitro, in comparison to the control group.
The tested chemosterilant proved capable of producing numerical and structural chromosomal aberrations in human lymphocytes in vitro.
CITOGENETIČKE PROMENE U KULTURI LIMFOCITA INDUKOVANE MESTRANOLOM
TEODOROVIĆ Radislava, DRAŠKOVIĆ Vladimir, ĐURIĆ Spomenka, NENADOVIĆ Kartarina, MIRILOVIĆ Milorad, JANKOVIĆ Ljiljana U ovom radu su izvršena ispitivanja genotoksičnih svojstava mestranola u različitim dozama: 7,5, 15 i 30 µg/g kulture ćelija -humanih limfocita, tokom ekspozicije od 3 dana, u uslovima "in vitro". Procena genotoksičnih efekata mestranola urađena je na osnovu numeričkih i strukturnih aberacija u tri eksperimentalne grupe sa po jednom kontrolnom za svaku dozu. Na osnovu rezultata naših ispitivanja može se zaključiti da mestranol u testiranim dozama dovodi do genotoksičnih efekata na limfocitima čoveka. Broj numeričkih aberacija se povećavao sa rastom doze i statističkom analizom su utvrđene signifi kantne razlike (<0,01) u odnosu na kontrolne grupe, ali ne i između primenjenih doza (>0,05). U slučaju poliploidija nije utvrđena statistički značajna razlika u odnosu na kontrolnu grupu (>0,05). Analizirajući dobijene rezultate utvrđeno je da sa povećanjem doze pri istoj ekspoziciji dolazi do statistički značajnog (<0,01) povećanja broja strukturnih aberacija na limfocitima, pri čemu najviši nivo je postignut kod najviše primenjene doze (30 µg/g c.c.). Kada su u pitanju Robertsonove translokacije statistička značajnost u odnosu na kontrolnu grupu utvrđena je tek kod najviše primenjene doze (30 µg/g c.c.). Statistički značajne razlike (p<0,01) su zabeležene između doza od 30 µg/g c.c i 7,5 µg/g c.c. Takođe statistički značajne razlike između nivoa otvora i fragmenata mogu se uporediti sa Robertsonovim translokacijama (p<0,01), dok se broj otvora fragmenata neće značajno promeniti.
